University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 19 of 26

COMPLETED NA

Interventions to Help Smoking Parents of Inpatients Reduce Exposure (INSPIRE)

NCT02281864

COMPLETED

Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes (ETT).

NCT02181894

COMPLETED

Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.

NCT02258685

COMPLETED

Prospective Identification of Long QT Syndrome in Fetal Life

NCT02876380

TERMINATED

Evaluation of Potential Allergenicity of New Wheat Varieties

NCT02341040

COMPLETED NA

Effect of Breaking up Prolonged Sitting on Metabolic Flexibility

NCT02258438

COMPLETED

Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation

NCT02428894

COMPLETED Phase 4

Positive Expiratory Pressure for the Treatment of Acute Asthma in Children

NCT02494076

COMPLETED NA

Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease

NCT02360644

COMPLETED NA

A Pilot Study: Snacking, Willpower and Glucose Availability

NCT02258477

COMPLETED NA

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

NCT02372383

COMPLETED NA

Alterations in Muscle After Total Knee Arthroplasty

NCT02281877

COMPLETED

Adolescents With Migraine: What's Stress Got To Do With It?

NCT02259387

COMPLETED NA

Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

NCT02122198

COMPLETED

Endothelial Microparticles: A Novel Marker of Vascular Dysfunction

NCT02230202

COMPLETED NA

Influence of a Monopoly Game on Subtle Behaviors

NCT02470949

COMPLETED

Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate

NCT02307877

COMPLETED Phase 4

Treatment of Tracheostomy Granulomas

NCT02116608

COMPLETED NA

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

NCT02026102

TERMINATED NA

Pharmacogenetic Prediction of Metoprolol Effectiveness

NCT02293096

COMPLETED

Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation

NCT02480270

COMPLETED

Glycemic Monitoring in Cystic Fibrosis

NCT02211235

COMPLETED Phase 2

Liver and Fat Regulation in Overweight Adolescent Girls

NCT02157974

COMPLETED NA

The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women

NCT02256540

COMPLETED

Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

NCT02229032

COMPLETED

The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

NCT02165631

COMPLETED

Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

NCT02213484

COMPLETED

Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata

NCT02216435

COMPLETED

Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?

NCT02588053

COMPLETED NA

Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women

NCT01894581

COMPLETED

How Infant Diets Would Affect Growth in Early Childhood

NCT02440503

COMPLETED NA

Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination

NCT02145156

COMPLETED NA

Educational Intervention to Improve HPV Vaccination Decision Quality

NCT02797054

COMPLETED Phase 1

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

NCT02114333

COMPLETED NA

Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal

NCT02140970

COMPLETED NA

Home-Based Mental Health Evaluation (HOME)

NCT03347552

COMPLETED NA

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

NCT01992016

COMPLETED

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

NCT02067663

COMPLETED Phase 1

Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots

NCT02022657

COMPLETED

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

NCT02530749

COMPLETED

Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease

NCT02058719

COMPLETED NA

Effect of Protein From Complementary Foods on Infant Growth, Body Composition and Gut Health

NCT02142647

COMPLETED

Local Fields Potentials Recorded From Deep Brain Stimulating Electrodes

NCT02071446

COMPLETED

Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor

NCT02920346

COMPLETED NA

The Effects of Exercise on Appetite Regulation in Overweight/Obese Individuals

NCT02047721

COMPLETED NA

Collaborative-care Intervention to Promote Physical Activity After Total Knee Arthroplasty

NCT02075931

COMPLETED

Validation of Triggered EMG Values for Pedicle Screws Using a Powered Screwdriver

NCT02064101

COMPLETED Phase 4

Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach

NCT02135146

COMPLETED

Comparison of Physiological Variables During Blood Donation

NCT02029807

COMPLETED NA

Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease

NCT02031770

← Previous Page 19 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.